Related Experiment Video
Updated: Jun 12, 2026

HOX Loci Focused CRISPR/sgRNA Library Screening Identifying Critical CTCF Boundaries
Published on: March 31, 2019
Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification
Ersen Kavak1, Ayaz Najafov, Nuri Ozturk
1Department of Molecular Biology and Genetics, Bogazici University, Istanbul, Turkey. ersen.kavak@ki.se
Abstract:
The Wnt signaling pathway is involved in many differentiation events during embryonic development and can lead to tumor formation after aberrant activation of its components. beta-catenin, a cytoplasmic component, plays a major role in the transduction of canonical Wnt signaling. The aim of this study was to identify novel genes that are regulated by active beta-catenin/TCF signaling in hepatocellular carcinoma-derived Huh7 cells with high (transfected) and low beta-catenin/TCF activities. High TCF activity Huh7 cells led to earlier and larger tumor formation when xenografted into nude mice. SAGE (Serial Analysis of Gene Expression), genome-wide microarray and in silico promoter analysis were performed in parallel, to compare gene expression between low and high beta-catenin/TCF activity clones, and also those that had been rescued from the xenograft tumors. SAGE and genome-wide microarray data were compared and contrasted. BRI3 and HSF2 were identified as novel targets of Wnt/beta-catenin signaling after combined analysis and confirming experiments including qRT-PCR, ChIP, luciferase assay and lithium treatment.
Insights
Researchers identified novel Wnt/beta-catenin signaling targets, BRI3 and HSF2, in hepatocellular carcinoma cells. This pathway
Area of Science:
- Molecular Biology
- Cancer Research
- Signal Transduction
Background:
- The Wnt signaling pathway regulates embryonic development and is implicated in tumor formation.
- Beta-catenin is a key mediator of canonical Wnt signaling.
- Aberrant Wnt signaling is a hallmark of various cancers, including hepatocellular carcinoma.
Purpose of the Study:
- To identify novel genes regulated by active beta-catenin/TCF signaling in hepatocellular carcinoma cells.
- To investigate the role of Wnt/beta-catenin signaling in tumor formation using hepatocellular carcinoma-derived Huh7 cells.
- To compare gene expression profiles in cells with varying beta-catenin/TCF activities.
Main Methods:
- Serial Analysis of Gene Expression (SAGE) and genome-wide microarray analysis.
- In silico promoter analysis to identify potential regulatory elements.
- Xenografting of Huh7 cells into nude mice to assess tumor formation.
- Quantitative real-time PCR (qRT-PCR), Chromatin Immunoprecipitation (ChIP), luciferase assays, and lithium treatment for validation.
Main Results:
- Huh7 cells with high beta-catenin/TCF activity exhibited earlier and larger tumor formation in vivo.
- Comparative analysis of SAGE and microarray data revealed distinct gene expression patterns.
- BRI3 and HSF2 were identified as novel target genes of Wnt/beta-catenin signaling.
- Experimental validation confirmed BRI3 and HSF2 as direct targets.
Conclusions:
- Wnt/beta-catenin signaling plays a significant role in hepatocellular carcinoma progression and tumorigenesis.
- BRI3 and HSF2 are novel downstream targets of the Wnt/beta-catenin pathway in hepatocellular carcinoma.
- Understanding these novel targets could lead to new therapeutic strategies for liver cancer.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Cis-regulatory Sequences